Pharma Journalist -

Exelixis, Inc. and NBE-Therapeutics announced a partnership to discover and develop multiple antibody-drug conjugates (ADCs) for oncology applications by leveraging NBE’s unique…
Read More...

AnGes, Inc. announced a collaboration agreement with Brickell Biotech, Inc. a clinical-stage pharmaceutical company, through which Brickell has the right to develop AnGes’ proprietary…
Read More...

Mylan N.V. announced an agreement to acquire the related intellectual property and commercialization rights of Aspen Pharmacare Holdings Limited's thrombosis business in Europe for EUR…
Read More...

Immune Regulation Ltd, a US and UK based clinical stage biotechnology company, announced that it has received a notice of allowance from the U.S. Patent and Trademark Office (USPTO) for…
Read More...

AnHeart Therapeutics, Co., Ltd. a clinical stage oncology company focused on underserved patients in global markets, has through its subsidiary AnHeart Therapeutics Inc. entered into…
Read More...

Grifols announced it has entered into a transaction to acquire the remaining equity of Alkahest, Inc. in exchange for a total price of $146 million, on a debt-free basis. No additional…
Read More...

Destiny Pharma plc, a clinical stage biotechnology company focused on the development of novel, hospital infection prevention treatments that address the global challenge of…
Read More...

IcanoMAB, a privately-funded biotech company focusing on the pre-clinical and clinical development of novel precision canonical antibodies for the treatment of cancer, immune-system…
Read More...

SMi reports: HEUFT to host a free exclusive webinar Pulsed x-ray technology & smart optics for a total inspection of pre-fillable syringe cannulas and needle shields, taking place…
Read More...

Kite, a Gilead Company announced that it has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Yescarta (axicabtagene…
Read More...